Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis

Human Reproduction

Volumn 24, Issue 5, 2009, Pages 1133-1141

  Kim, Sung Hoon ^a   Lee, Hoi Woul ^a   Kim, Young Hoon ^a   Koo, Yun Hee ^a   Chae, Hee Dong ^a   Kim, Chung Hoon ^a   Lee, Pil Ryang ^a   Kang, Byung Moon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Endometriosis; Endometrium; P21 activated kinase 1; Progestin

Indexed keywords

CRYSTAL VIOLET; CYTOKERATIN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; P21 ACTIVATED KINASE 1; SMALL INTERFERING RNA; VIMENTIN;

ADULT; ARTICLE; CARCINOMA IN SITU; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO GENE TRANSFER; IN VITRO STUDY; MENSTRUAL CYCLE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA INTERFERENCE; STROMA CELL; UPREGULATION; WESTERN BLOTTING;

EID: 67449149848     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den484     Document Type: Article

References (25)

1. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817-821.
2. Arid A, Head JR, MacDonald PC, Casey ML. Regulation of interleukin 8 gene expression in human endometrial cells in culture. Mol Cell Endocrinol 1993;94:195-204.
3. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R. p21 -activated kinase-1 signaling mediates cyclin Dl expression in mammary epithelial and cancer cells. J Biol Chem 2004a; 279:1422-1428.
4. Balasenthil S, Barnes CJ, Rayala SK, Kumar R. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin Dl in breast cancer cells. FEBS Lett 2004b;567:243-247.
5. Banerjee M, Worth D, Prowse DM, Nikolic M. Pakl phosphorylation on t2l2 affects microtubules in cells undergoing mitosis. Curr Biol 2002; 12:1233-1239.
6. Bokoch GM. Biology of the p21 activated kinases. Annu Rev Biochem 2003; 72:743-781.
7. Bulun SE, Cheng YH, Yin P, Imir G, Utsunomiya H, Attar E, Innes J, Julie Kim J. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 2006;248:94-103.
8. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003;144:2870-2881.
9. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002;47:213-221.
10. King CC, Gardiner EM, Zenke FT, Bohl BP, Newton AC, Hemmings BA, Bokoch GM. p21 activated kinase (PAKI) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDKI). J Biol Chem 2000;275:41201-41209.
11. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997;57:514-519.
12. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S, Honjo H. Detection of aromatase cytochrome P 450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999; 72:1100-1106.
13. Koshiba H, Kitawaki J, Teramoto M, Kitaoka Y, Ishihara H, Obayashi H, Ohta M, Hara H, Adachi T, Honjo H. Expression of allograft inflammatory factor-1 in human eutopic endometrium and endometriosis: possible association with progression of endometriosis. J Clin Endocrinol Metab 2005;90:529-537.
14. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Not Rev Cancer 2006;6:459-471.
15. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L A brain serine/ threonine protein kinase activated by Cdc42 and Racl. Nature 1994; 367:40-46.
16. Mazumdar A, Kumar R. Estrogen regulation of Pakl and FKHR pathways in breast cancer cells. FEBS Lett 2003;535:6-10.
17. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975;122:262-263.
18. Osada S, Izawa M, Koyama T, Hirai S, Ohno S. A domain containing the Cdc42/Rac interactive binding (CRIB) region of p65PAK inhibits transcriptional activation and cell transformation mediated by the Ras Rac pathway. FEBS Lett 1997;404:227-233.
19. Osteen KG, Bruner Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril 2005;83:529-537.
20. Tang Y, Chen Z, Ambrose D, Liu J, Gibbs JB, Chernoff J, Field J. Kinase-deficient Pakl mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol Cell Biol 1997;17:4454-4464.
21. Thiel DA, Reeder MK, Pfaff A, Coleman TR, Sells MA, Chernoff J. Cell cycle-regulated phosphorylation of p21-activated kinase I. Curr Biol 2002;12:1227-1232.
22. Tseng L, Gurpide E. Effects of progestins on estradiol receptor levels in human endometrium. J Clin Endocrinol Metab 1975;41:402-404.
23. Vadlamudi RK, Adam L, Wang RA, Mandai M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R. Regulatable expression of p21 activated kinase-1 promotes anchorage independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 2000;275:36238- 36244.
24. Wang RA, Mazumdar A, Vadlamudi RK, Kumar R. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J 2002; 21:5437-5447.
25. Wang RA, Zhang H, Balasenthil S, Medina D, Kumar R. PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 2006;25:2931-2936.